LoginSignup
iShares NASDAQ US Biotechnology ETF logo

iShares NASDAQ US Biotechnology ETF

ETF
ETF
ISIN: IE00BYXG2H39
Ticker: BTEC
IE00BYXG2H39
BTEC

Price

Price

CHART BY

Data

TER

 
0.35%

Fund Volume

 
$499.24M

Asset Class

 
Equity

Distributing

 
No

Replication Method

 
Physical Full

Region

 
U.S.

Country Based

 
Ireland

Issuer

 
iShares

Industry Breakdown

  • Major Pharmaceuticals
    52.34%
  • Biotechnology
    41.9%
  • Other Pharmaceuticals
    3.01%
  • Miscellaneous Commercial Services
    1.32%
  • Medical Specialties
    0.9%
  • Medical/ Nursing Services
    0.44%
  • Not Classified
    0.1%

Sector Breakdown

  • Health Care
    99.9%
  • Other
    0.1%

Region Breakdown

  • 🇺🇸

    USA
    83.92%

  • 🇬🇧

    United Kingdom
    5.98%

  • 🇳🇱

    Netherlands
    2.36%

  • 🇮🇪

    Ireland
    1.47%

  • 🇫🇷

    France
    1.45%

  • 🇩🇪

    Germany
    1.28%

  • 🇰🇾

    Cayman Islands
    0.97%

  • 🇩🇰

    Denmark
    0.89%

  • 🇨🇦

    Canada
    0.55%

  • 🇨🇭

    Switzerland
    0.48%

  • 🇸🇬

    Singapore
    0.19%

  • 🇨🇳

    China
    0.15%

  • 🏳️

    Other
    0.11%

  • 🇪🇸

    Spain
    0.09%

Frequently asked questions

What is the Total Expense Ratio (TER) of iShares NASDAQ US Biotechnology ETF?

The total expense ratio (TER) of iShares NASDAQ US Biotechnology ETF is 0.35%. The TER represents the annual fees charged by the ETF provider, covering management costs and operational expenses. A lower TER can enhance your investment returns over time.

What is the fund volume of iShares NASDAQ US Biotechnology ETF?

iShares NASDAQ US Biotechnology ETF has a fund volume of $499.24M. Fund volume indicates the total assets under management (AUM) and reflects the ETF's size and liquidity. Larger fund volumes generally offer better liquidity and tighter bid-ask spreads.

Is iShares NASDAQ US Biotechnology ETF paying dividends?

iShares NASDAQ US Biotechnology ETF is a Accumulating ETF. It reinvests dividends back into the fund, increasing the value of each share over time.

What is the replication method used by iShares NASDAQ US Biotechnology ETF?

iShares NASDAQ US Biotechnology ETF uses a physical full replication method. In this approach, the ETF purchases all the securities in the underlying index in the exact proportions as the index. This ensures the most precise tracking of the index's performance since the ETF's holdings mirror the index completely.

In which country is iShares NASDAQ US Biotechnology ETF domiciled?

iShares NASDAQ US Biotechnology ETF is domiciled in Ireland. The domicile country can affect tax implications and regulatory oversight, which may influence your investment decisions.

Pricing

1D span
$6.665$6.756
52W span
$5.823$7.195

Information

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Identifier

ISIN
IE00BYXG2H39
Primary Ticker
BTEC

Knockouts

Finance data from FactSet
Join the conversation
Sign upLogin